
Please try another search
In a challenging market environment, SurModics , Inc. (NASDAQ:SRDX) stock has recorded a new 52-week low, dipping to $26.21. According to InvestingPro data, the company's current market...
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported...
Investing.com - SurModics (NASDAQ: SRDX) reported second quarter EPS of $-0.13, $0.04 worse than the analyst estimate of $-0.09. Revenue for the quarter came in at $28.1M versus the consensus...
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that...
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the publication of the TRANSCEND clinical trial,...
EDEN PRAIRIE, Minn. - Surmodics, Inc. (NASDAQ:SRDX), a medical device and diagnostic technology provider with a market capitalization of $440 million and impressive gross margins of 75%, has announced...
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the commercial release of the Pounce™ XL...
EDEN PRAIRIE, Minn. - Surmodics, Inc. (NASDAQ:SRDX), a medical technology firm with a market capitalization of $424 million, is set to defend its planned merger with affiliates of GTCR LLC in court,...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review